Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms

Endocrinology

Volumn 144, Issue 8, 2003, Pages 3449-3455

  Simoncini, Tommaso ^a   Mannella, Paolo ^a   Fornari, Letizia ^a   Varone, Gaetano ^a   Caruso, Antonella ^a   Genazzani, Andrea R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIESTROGEN; ANTIGESTAGEN; ESTROGEN; GLUCOCORTICOID; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PRASTERONE; PROTEIN KINASE B;

ANDROGEN METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME STABILITY; ESTROGEN METABOLISM; FEMALE; GENE EXPRESSION REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; DEHYDROEPIANDROSTERONE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; GTP-BINDING PROTEINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; UMBILICAL VEINS;

EID: 0042816523     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0044     Document Type: Article

References (33)

1. Baulieu E-E, Corpechot C, Dray F, Emiliozzi R, Lebeau M-C, Mauvais-Jarvis P, Robel P 1965 An adrenal secreted androgen:dehydroepiandrosterone sulfate. Its metabolism and a tentative generalisation on the matabolism of other steroid conjugates in man. Recent Prog Horm Res 21:411-500
2. Orentreich N, Matias JR, Malloy V 1984 The local antiandrogenic effect of the intracutaneous injection of progesterone in the flank organ of sexually mature male Syrian golden hamster. Arch Dermatol Res 276:401-405
3. Belanger A, Candas B, Dupont A, Cusan L, Diamond P, Gomez JL, Labrie F 1994 Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab 79:1086-1090
4. Lasley BL, Santoro N, Randolf JF, Gold EB, Crawford S, Weiss G, McConnell DS, Sowers MF 2002 The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 87:3760-3767
5. Barrett-Connor E, Khaw KT, Yen SS 1986 A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315:1519-1524
6. Slowinska-Srzednicka J, Zgliczynski S, Soszynski P, Makowska A, Zgliczynski W, Srzednicki M, Bednarska M, Chotkowska E, Woroszylska M, Ruzyllo W 1991 Decreased plasma levels of dehydroepiandrosterone sulphate (DHEA-S) in normolipidaemic and hyperlipoproteinaemic young men with coronary artery disease. J Intern Med 230:551-553
7. Slowinska-Srzednicka J, Malczewska B, Srzednicki M, Chotkowska E, Brzezinska A, Zgliczynski W, Ossowski M, Jeske W, Zgliczynski S, Sadowski Z 1995 Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med 237:465-472
8. Johannes CB, Stellato RK, Feldman HA, Longcope C, McKinlay JB 1999 Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study. J Clin Epidemiol 52:95-103
9. Mitchell LE, Sprecher DL, Borecki IB, Rice T, Laskarzewski PM, Rao DC 1994 Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation 89:89-93
10. Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HF, Kwiterovich Jr PO, Pearson TA 1990 Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 16:862-870
11. Herrington DM, Nanjee N, Achuff SC, Cameron DE, Dobbs B, Baughman KL 1996 Dehydroepiandrosterone and cardiac allograft vasculopathy. J Heart Lung Transplant 15:88-93
12. Barrett-Connor E, Goodman-Gruen D 1995 The epidemiology of DHEAS and cardiovascular disease. Ann NY Acad Sci 774:259-270
13. Berr C, Lafont S, Debuire B, Dartigues JF, Baulieu EE 1996 Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci USA 93:13410-13415
14. Mazat L, Lafont S, Berr C, Debuire B, Tessier JF, Dartigues JF, Baulieu EE 2001 Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci USA 98:8145-8150
15. Christopher-Hennings J, Kurzman ID, Haffa AL, Kemnitz JW, Macewen EG 1995 The effect of high fat diet and dehydroepiandrosterone (DHEA) administration in the rhesus monkey. In Vivo 9:415-420
16. Gordon GB, Bush DE, Weisman HF 1988 Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand White rabbit with aortic intimal injury. J Clin Invest 82:712-720
17. Eich DM, Nestler JE, Johnson DE, Dworkin GH, Ko D, Wechsler AS, Hess ML 1993 Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation 87:261-269
18. Simoncini T, Genazzani AR 2000 Direct vascular effects of estrogens and selective estrogen receptor modulators. Curr Opin Obstet Gynecol 12:181-187
19. Simoncini T, Genazzani AR 2003 Non-genomic actions of sex steroid hormones. Eur J Endocrinol 148:281-292
20. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Forstermann U 1998 Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31:582-588
21. Simoncini T, Hafezi-Moghadam A, Brazil D, Ley K, Chin WW, Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541
22. Hayashi T, Esaki T, Muto E, Kano H, Asai Y, Thakur NK, Sumi D, Jayachandran M, Iguchi A 2000 Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide. Arterioscler Thromb Vasc Biol 20:782-792
23. i2,3. J Biol Chem 277:21379-21388
24. Liao JK 1999 Endothelial nitric oxide and vascular inflammation. In: Panza JA, Cannon ROI, eds. Endothelium, nitric oxide and atherosclerosis. Armonk: Futura; 119-132
25. Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, Lanzone A, Genazzani AR, Petraglia F 1999 Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab 84:2802-2806
26. Knowles RG, Salter M 1998 Measurement of NOS activity by conversion of radiolabeled arginine to citrulline using ion-exchange separation. In: Titheradge MA, ed. Nitric oxide protocols. Totowa, NJ: Humana Press; 67-73
27. Simoncini T, Genazzani AR 2000 Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. J Clin Endocrinol Metab 85:2966-2969
28. Hafezi-Moghadam A, Simoncini T, Yang E, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JK 2002 Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8:473-479
29. Chang L, Karin M 2001 Mammalian MAP kinase signalling cascades. Nature 410:37-40
30. Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR 2000 Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Gynecol Endocrinol 14:342-363
31. Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Bing X, Lund DD, Dillon JS 2002 Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol 283:E1067-E1075
32. Gutkind JS 1998 The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273:1839-1842
33. Williams MRI, Ling S, Dawood T, Hashimura K, Dai A, Li H, Liu J-P, Funder JW, Sudhir K, Komesaroff PA 2002 Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab 87:176-181